2023
DYRK1A promotes viral entry of highly pathogenic human coronaviruses in a kinase-independent manner
Strine M, Cai W, Wei J, Alfajaro M, Filler R, Biering S, Sarnik S, Chow R, Patil A, Cervantes K, Collings C, DeWeirdt P, Hanna R, Schofield K, Hulme C, Konermann S, Doench J, Hsu P, Kadoch C, Yan Q, Wilen C. DYRK1A promotes viral entry of highly pathogenic human coronaviruses in a kinase-independent manner. PLOS Biology 2023, 21: e3002097. PMID: 37310920, PMCID: PMC10263356, DOI: 10.1371/journal.pbio.3002097.Peer-Reviewed Original ResearchConceptsGenome-wide CRISPR/Cas9 screenCRISPR/Cas9 screenPathogenic human coronavirusesKinase-independent mannerRegulated kinase 1AProviral host factorNovel drug targetsMultiple cell typesDNA accessibilityHost factorsKinase functionHuman coronavirusesHost genesDistal enhancerNovel regulatorCas9 screenKinase 1AGene expressionNeuronal developmentDYRK1ADrug targetsDiverse coronavirusesProviral activityCell typesSevere acute respiratory syndrome coronavirus 2
2015
MG-112 Ten new cases further delineate the syndromic intellectual disability phenotype caused by mutations in DYRK1A
Bronicki L, Redin C, Drunat S, Piton A, Lyons M, Passemard S, Baumann C, Faivre L, Thevenon J, Rivière J, Isidor B, Gan G, Francannet C, Gunel M, Jones J, Gleeson J, Willems M, Mandel J, Stevenson R, Friez M, Aylsworth A. MG-112 Ten new cases further delineate the syndromic intellectual disability phenotype caused by mutations in DYRK1A. Journal Of Medical Genetics 2015, 52: a2. DOI: 10.1136/jmedgenet-2015-103577.6.Peer-Reviewed Original ResearchDual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) geneDNA sequence variationExome next-generation sequencingLarge chromosomal deletionsDown syndrome critical regionIntellectual disability phenotypeIdentification of mutationsWhole-exome next-generation sequencingIntellectual disabilitySyndrome critical regionComparative genomic hybridization analysisNext-generation sequencingSyndromic intellectual disabilityChromosomal rearrangementsMultiple genesSequence variationGenomic hybridization analysisRecurrent clinical featuresTypes of mutationsDYRK1AHybridization analysisArray comparative genomic hybridization analysisChromosomal deletionsPoor weight gainDisability phenotype
2009
Down's syndrome suppression of tumour growth and the role of the calcineurin inhibitor DSCR1
Baek KH, Zaslavsky A, Lynch RC, Britt C, Okada Y, Siarey RJ, Lensch MW, Park IH, Yoon SS, Minami T, Korenberg JR, Folkman J, Daley GQ, Aird WC, Galdzicki Z, Ryeom S. Down's syndrome suppression of tumour growth and the role of the calcineurin inhibitor DSCR1. Nature 2009, 459: 1126-1130. PMID: 19458618, PMCID: PMC2724004, DOI: 10.1038/nature08062.Peer-Reviewed Original ResearchMeSH KeywordsAnimalsCalcineurinCalcium-Binding ProteinsCatecholsCells, CulturedDisease Models, AnimalDNA-Binding ProteinsDown SyndromeEndothelial CellsGene DosageHumansInositolIntracellular Signaling Peptides and ProteinsMiceMice, TransgenicMuscle ProteinsProtein Serine-Threonine KinasesProtein-Tyrosine Kinases
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply